Obesity and diabetes: The twin pandemics

Ilana Harman-Boehm, Rachel Pope

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

1 Scopus citations


Obesity and diabetes have been called the twin pandemics of the new millennium. Obesity promotes insulin resistance that in turn leads to atherogenic dyslipidemia, hypertension, impaired fibrinolysis and impaired glucose metabolism. Concomitantly, enhanced inflammation and oxidative stress, induced by visceral adipose tissue, contribute to accelerated atherosclerosis and cardiovascular disease. Treatment begins with prevention of obesity through lifestyle modification such as dietary change and exercise. Unfortunately, adherence to such lifestyle changes is poor. Pharmacologic treatment and bariatric surgery provide additional options, however, with varying outcomes. Glycemic control is an additional related issue, which also requires medical intervention such as oral hypoglycemics, anti-hyperglycemics and/or insulin, singly or in combination. Various treatment regimens for obesity and diabetes meet, at best, with partial success, therefore the staving of the "twin pandemics" and the resultant excessive cardiovascular morbidity and mortality, is only possible by effective prevention strategies that need to be implemented globally, nationally and locally.

Original languageEnglish
Title of host publicationObesity in Pregnancy
Subtitle of host publicationA Comprehensive Guide
PublisherNova Science Publishers, Inc.
Number of pages12
ISBN (Print)9781617286124
StatePublished - 1 Jan 2011
Externally publishedYes

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology
  • General Medicine


Dive into the research topics of 'Obesity and diabetes: The twin pandemics'. Together they form a unique fingerprint.

Cite this